Inogen Inc  

(Public, NASDAQ:INGN)   Watch this stock  
Find more results for NYSE:INGN
69.11
-0.11 (-0.16%)
After Hours: 69.11 0.00 (0.00%)
Feb 27, 4:42PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 68.40 - 69.74
52 week 32.49 - 69.94
Open 69.66
Vol / Avg. 300,229.00/109,382.00
Mkt cap 1.41B
P/E 97.46
Div/yield     -
EPS 0.71
Shares 20.26M
Beta     -
Inst. own 103%
Mar 13, 2017
Q4 2016 Inogen Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jan 12, 2017
Inogen Inc at Needham Growth Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 6.35% 7.29%
Operating margin 9.92% 9.47%
EBITD margin - 18.28%
Return on average assets 7.34% 7.69%
Return on average equity 9.13% 9.19%
Employees 547 -
CDP Score - -

Address

326 Bollay Dr
GOLETA, CA 93117-5550
United States - Map
+1-805-5620500 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Inogen, Inc. is a medical technology company. The Company is engaged in developing, manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device weighing approximately 4.8 or seven pounds. Its Inogen One G2 and Inogen One G3 have approximately five and 4.5 hours of battery life, respectively, with a single battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory patient market and serves as a backup to its Inogen One system for ambulatory patients. The Company sells its products to home medical equipment providers in the United States and in foreign countries.

Officers and directors

Heath Lukatch Ph.D. Independent Chairman of the Board
Age: 48
Bio & Compensation  - Reuters
Scott Wilkinson President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Raymond O. Huggenberger Director
Age: 57
Bio & Compensation  - Reuters
Alison Bauerlein Chief Financial Officer, Executive Vice President - Finance, Treasurer, Secretary
Age: 34
Bio & Compensation  - Reuters
Byron Myers Executive Vice President of Sales and Marketing
Age: 36
Bio & Compensation  - Reuters
Matthew Scribner Executive Vice President - Operations
Age: 48
Bio & Compensation  - Reuters
Brenton Taylor Executive Vice President - Engineering
Age: 34
Bio & Compensation  - Reuters
Scott A. Beardsley Director
Age: 48
Bio & Compensation  - Reuters
Benjamin M. Anderson-Ray Independent Director
Age: 61
Bio & Compensation  - Reuters
R. Scott Greer Independent Director
Age: 57
Bio & Compensation  - Reuters